204 related articles for article (PubMed ID: 22117551)
1. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
[TBL] [Abstract][Full Text] [Related]
2. Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Lesovaya E; Yemelyanov A; Kirsanov K; Popa A; Belitsky G; Yakubovskaya M; Gordon LI; Rosen ST; Budunova I
Cell Cycle; 2013 Jan; 12(1):133-44. PubMed ID: 23255118
[TBL] [Abstract][Full Text] [Related]
3. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
4. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
[TBL] [Abstract][Full Text] [Related]
5. Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Yemelyanov A; Bhalla P; Yang X; Ugolkov A; Iwadate K; Karseladze A; Budunova I
Cell Cycle; 2012 Jan; 11(2):395-406. PubMed ID: 22223138
[TBL] [Abstract][Full Text] [Related]
6. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
7. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
[TBL] [Abstract][Full Text] [Related]
8. A fully dissociated compound of plant origin for inflammatory gene repression.
De Bosscher K; Vanden Berghe W; Beck IM; Van Molle W; Hennuyer N; Hapgood J; Libert C; Staels B; Louw A; Haegeman G
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15827-32. PubMed ID: 16243974
[TBL] [Abstract][Full Text] [Related]
9. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
[TBL] [Abstract][Full Text] [Related]
10. GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.
Barcala Tabarrozzi AE; Andreone L; Deckers J; Castro CN; Gimeno ML; Ariolfo L; Berguer PM; Antunica-Noguerol M; Liberman AC; Vettorazzi S; Tuckermann JP; De Bosscher K; Perone MJ
Sci Rep; 2016 Nov; 6():36646. PubMed ID: 27857212
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.
Wüst S; Tischner D; John M; Tuckermann JP; Menzfeld C; Hanisch UK; van den Brandt J; Lühder F; Reichardt HM
PLoS One; 2009 Dec; 4(12):e8202. PubMed ID: 19997594
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
Strauss SJ; Higginbottom K; Jüliger S; Maharaj L; Allen P; Schenkein D; Lister TA; Joel SP
Cancer Res; 2007 Mar; 67(6):2783-90. PubMed ID: 17363600
[TBL] [Abstract][Full Text] [Related]
13. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
Drebert Z; Bracke M; Beck IM
J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
[TBL] [Abstract][Full Text] [Related]
15. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways.
Lauricella M; Emanuele S; D'Anneo A; Calvaruso G; Vassallo B; Carlisi D; Portanova P; Vento R; Tesoriere G
Apoptosis; 2006 Apr; 11(4):607-25. PubMed ID: 16528474
[TBL] [Abstract][Full Text] [Related]
16. Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
Kinjo T; Kowalczyk P; Kowalczyk M; Walaszek Z; Nishimaki T; Slaga TJ; Hanausek M
Mol Carcinog; 2009 Dec; 48(12):1123-30. PubMed ID: 19575421
[TBL] [Abstract][Full Text] [Related]
17. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
[TBL] [Abstract][Full Text] [Related]
18. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
20. Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity.
Avenant C; Ronacher K; Stubsrud E; Louw A; Hapgood JP
Mol Cell Endocrinol; 2010 Oct; 327(1-2):72-88. PubMed ID: 20561560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
